Advance confident discovery biology decisions
From mechanism insights to confident target validation, biology teams need faster, evidence-driven answers to guide small and large molecule strategies. CAS BioFinder helps leading teams overcome fragmentation and move discovery forward.
Stronger, faster insights for therapeutic strategies
Discovery biology teams face mounting pressure to deliver faster insights that guide therapeutic strategy, whether for small molecules or large biologics. In a landscape where delays can mean missed opportunities, biology leaders need solutions that cut through fragmentation and enable rapid, evidence-based decisions.
How can we better understand the mechanisms of a specific disease?
Inform research paths with an understanding of the disease’s mechanisms and pathogenesis using CAS BioFinder. Instead of wrestling with inconsistent identifiers and fragmented biomarker evidence, CAS BioFinder provides standardized disease details, associated biomarkers, and linked assay details, allowing you to quickly build a high-quality mechanism brief.
How can we identify the most biologically and clinically relevant targets for our disease of interest?
Find potential new targets for disease treatment faster with CAS BioFinder. AI-driven biomarker summaries, protein browsing with precise filters, and assay-linked measurement tables help you rank targets objectively and cut through noisy lists with confidence.
How can we learn how our target protein functions in the body?
Identify early signals of therapeutic potential by connecting protein structure to biological role with CAS BioFinder. Explore protein summaries, interactive 3D structures, and pathway visualizations to validate mechanisms of action and understand upstream and downstream effects—all in one place.
How can we confidently validate our target before passing it to the chemistry team?
Confirm a target’s therapeutic relevance and avoid wasted chemistry cycles with CAS BioFinder’s target validation tools. BLAST searches for novelty, interactive 3D binding site analysis, and pharmacology data enhanced with toxicity predictions ensure that you pass a thoroughly vetted target along the pipeline.
How can we design an antibody or peptide to deliver the chemistry team’s drug to the target?
Design the best possible delivery mechanism for the proposed therapy with CAS BioFinder’s unified view of biology and chemistry data. Access structure and sequence details, known antibody and peptide data. Make rapid connections across disease, target, ligand, and pharmacology insights to inform delivery design and innovation.
Ready to start a free trial for your discovery biology team?
